回复：295例临床晚期膀胱尿路上皮癌的综合基因组分析揭示了临床相关基因组改变的高频率。 - Suppr | 超能文献

Re: Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic Alterations.

作者信息

Chang Sam S

出版信息

J Urol. 2017 Feb;197(2):319. doi: 10.1016/j.juro.2016.11.040. Epub 2016 Nov 15.

DOI:10.1016/j.juro.2016.11.040

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Re: Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic Alterations.回复：295例临床晚期膀胱尿路上皮癌的综合基因组分析揭示了临床相关基因组改变的高频率。

J Urol. 2017 Feb;197(2):319. doi: 10.1016/j.juro.2016.11.040. Epub 2016 Nov 15.

2

Re: Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic Alterations.回复：对295例临床晚期膀胱尿路上皮癌进行综合基因组分析揭示了临床相关基因组改变的高频率。

Eur Urol. 2016 Aug;70(2):400-1. doi: 10.1016/j.eururo.2016.03.067. Epub 2016 Apr 18.

3

Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.对 295 例临床晚期膀胱癌进行全面基因组分析，揭示了临床上相关的基因组改变的高频率。

Cancer. 2016 Mar 1;122(5):702-11. doi: 10.1002/cncr.29826. Epub 2015 Dec 9.

4

Re: Occult Metastases in Pelvic Lymphadenectomy Specimens from Patients with Urothelial Carcinoma of the Bladder.关于：膀胱癌尿路上皮癌患者盆腔淋巴结清扫标本中的隐匿性转移

J Urol. 2017 May;197(5):1218-1219. doi: 10.1016/j.juro.2017.02.016. Epub 2017 Feb 9.

5

Genomics in upper tract urothelial carcinoma.上尿路尿路上皮癌的基因组学

Curr Opin Urol. 2017 Jan;27(1):35-40. doi: 10.1097/MOU.0000000000000341.

6

Re: Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis from the National Cancer Data Base.回复：高强度局部治疗对膀胱转移性尿路上皮癌的疗效：来自国家癌症数据库的倾向评分加权分析

Eur Urol. 2016 Nov;70(5):894. doi: 10.1016/j.eururo.2016.07.048. Epub 2016 Aug 3.

7

Re: Efficacy of High-intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis from the National Cancer Data Base.回复：高强度局部治疗对膀胱转移性尿路上皮癌的疗效：来自国家癌症数据库的倾向评分加权分析

Eur Urol. 2016 Nov;70(5):893. doi: 10.1016/j.eururo.2016.07.040. Epub 2016 Aug 4.

8

Re: Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis from the National Cancer Data Base.关于：高强度局部治疗对膀胱转移性尿路上皮癌的疗效：来自国家癌症数据库的倾向评分加权分析

J Urol. 2018 Jun;199(6):1396. doi: 10.1016/j.juro.2018.03.018. Epub 2018 Mar 16.

9

Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma.FGFR3基因改变谱：FGFR3在晚期尿路上皮癌中潜在作用的当前评估

BJU Int. 2016 Nov;118(5):681-691. doi: 10.1111/bju.13552. Epub 2016 Jul 7.

10

Re: Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.关于：早期尿路上皮癌的综合转录分析

Eur Urol. 2016 Dec;70(6):1076. doi: 10.1016/j.eururo.2016.08.029. Epub 2016 Aug 25.